Literature DB >> 15035902

Vitamin C in alternative cancer treatment: historical background.

Keith I Block1, Mark N Mead.   

Abstract

Ascorbic acid is the single-nutrient supplement most commonly used by cancer patients, although in most cases this takes place without the physician's knowledge or supervision. A comprehensive review of the literature is presented on the impact of ascorbic acid on cancer survival. Findings from 6 uncontrolled studies suggest that ascorbic acid may increase survival, whereas 2 controlled trials have yielded null results. The relative strengths and limitations of these studies are discussed. A turning point occurred with the release of the 2 controlled (null) studies, which influenced many physicians to turn away from nutrition in the care of cancer patients. Controversy about these trials still persists, however, in the alternative cancer community.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15035902     DOI: 10.1177/1534735403002002007

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  3 in total

Review 1.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

2.  The prospects of vitamin C in cancer therapy.

Authors:  Wang-Jae Lee
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

3.  High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.

Authors:  L John Hoffer; Line Robitaille; Robert Zakarian; David Melnychuk; Petr Kavan; Jason Agulnik; Victor Cohen; David Small; Wilson H Miller
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.